Li Y - Search Results

1

Retraction of "Design and Synthesis of Novel Cyclic Amine Benzimidazoles for the Treatment of Pancreatic Cancer".

Pathak V, Augelli-Szafran CE, Wei HX, Li Y, Oliver PG, Lu W, Buchsbaum DJ, Suto MJ. Pathak V, et al. Among authors: li y. J Med Chem. 2017 Sep 14;60(17):7615. doi: 10.1021/acs.jmedchem.6b01417. J Med Chem. 2017. PMID: 28230988 No abstract available.

2

The Wnt/β-catenin signaling pathway: a potential therapeutic target in the treatment of triple negative breast cancer.

King TD, Suto MJ, Li Y. King TD, et al. Among authors: li y. J Cell Biochem. 2012 Jan;113(1):13-8. doi: 10.1002/jcb.23350. J Cell Biochem. 2012. PMID: 21898546 Free PMC article. Review.

3

Frizzled7 as an emerging target for cancer therapy.

King TD, Zhang W, Suto MJ, Li Y. King TD, et al. Among authors: li y. Cell Signal. 2012 Apr;24(4):846-51. doi: 10.1016/j.cellsig.2011.12.009. Epub 2011 Dec 13. Cell Signal. 2012. PMID: 22182510 Free PMC article. Review.

4

The C-terminal region Mesd peptide mimics full-length Mesd and acts as an inhibitor of Wnt/β-catenin signaling in cancer cells.

Lin C, Lu W, Zhang W, Londoño-Joshi AI, Buchsbaum DJ, Bu G, Li Y. Lin C, et al. Among authors: li y. PLoS One. 2013;8(2):e58102. doi: 10.1371/journal.pone.0058102. Epub 2013 Feb 28. PLoS One. 2013. PMID: 23469146 Free PMC article.

5

Effect of niclosamide on basal-like breast cancers.

Londoño-Joshi AI, Arend RC, Aristizabal L, Lu W, Samant RS, Metge BJ, Hidalgo B, Grizzle WE, Conner M, Forero-Torres A, Lobuglio AF, Li Y, Buchsbaum DJ. Londoño-Joshi AI, et al. Among authors: li y. Mol Cancer Ther. 2014 Apr;13(4):800-11. doi: 10.1158/1535-7163.MCT-13-0555. Epub 2014 Feb 19. Mol Cancer Ther. 2014. PMID: 24552774 Free PMC article.

6

Rottlerin induces Wnt co-receptor LRP6 degradation and suppresses both Wnt/β-catenin and mTORC1 signaling in prostate and breast cancer cells.

Lu W, Lin C, Li Y. Lu W, et al. Among authors: li y. Cell Signal. 2014 Jun;26(6):1303-9. doi: 10.1016/j.cellsig.2014.02.018. Epub 2014 Mar 6. Cell Signal. 2014. PMID: 24607787 Free PMC article.

7

Multi-targeted therapy of cancer by niclosamide: A new application for an old drug.

Li Y, Li PK, Roberts MJ, Arend RC, Samant RS, Buchsbaum DJ. Li Y, et al. Among authors: li pk. Cancer Lett. 2014 Jul 10;349(1):8-14. doi: 10.1016/j.canlet.2014.04.003. Epub 2014 Apr 13. Cancer Lett. 2014. PMID: 24732808 Free PMC article. Review.

8

Salinomycin suppresses LRP6 expression and inhibits both Wnt/β-catenin and mTORC1 signaling in breast and prostate cancer cells.

Lu W, Li Y. Lu W, et al. Among authors: li y. J Cell Biochem. 2014 Oct;115(10):1799-807. doi: 10.1002/jcb.24850. J Cell Biochem. 2014. PMID: 24905570 Free PMC article.

9

Identification of quinazoline compounds as novel potent inhibitors of Wnt/β-catenin signaling in colorectal cancer cells.

Li Y, Lu W, Saini SK, Moukha-Chafiq O, Pathak V, Ananthan S. Li Y, et al. Oncotarget. 2016 Mar 8;7(10):11263-70. doi: 10.18632/oncotarget.7019. Oncotarget. 2016. PMID: 26820295 Free PMC article.

10

Discovery of a novel inhibitor of kinesin-like protein KIFC1.

Zhang W, Zhai L, Wang Y, Boohaker RJ, Lu W, Gupta VV, Padmalayam I, Bostwick RJ, White EL, Ross LJ, Maddry J, Ananthan S, Augelli-Szafran CE, Suto MJ, Xu B, Li R, Li Y. Zhang W, et al. Among authors: li y, li r. Biochem J. 2016 Apr 15;473(8):1027-35. doi: 10.1042/BJ20150992. Epub 2016 Feb 4. Biochem J. 2016. PMID: 26846349 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

220,270 results

Search Page